Finance

Lists
ZYDUSWELL:NSE
Zydus Wellness Ltd
515,00 INR
+0,99%
(+5,05) 1D
16 ოქტ, 15:30:01 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ZYDUSWELL...
Open
512,85 INR
High
515,00 INR
Low
506,30 INR
Mkt. cap
163,85 მლრ.
Avg. vol.
427,71 ათ.
Volume
52,40 ათ.
Dividend
0,23%
Quarterly dividend
0,30 INR
Ex-dividend date
17 ივლ. 2026
P/E ratio
87,70
52-wk high
611,85 INR
52-wk low
367,55 INR
EPS
5,87 INR
Shares outstanding
39,07 მლნ.
No. of employees
2 ათ.
Open
512,85 INR
High
515,00 INR
Low
506,30 INR
Mkt. cap
163,85 მლრ.
Avg. vol.
427,71 ათ.
Volume
52,40 ათ.
Dividend
0,23%
Quarterly dividend
0,30 INR
Ex-dividend date
17 ივლ. 2026
P/E ratio
87,70
52-wk high
611,85 INR
52-wk low
367,55 INR
EPS
5,87 INR
Shares outstanding
39,07 მლნ.
No. of employees
2 ათ.
News stories
From web sources and news partners
medwatch.com
medwatch.com
·
15 წუთის წინ
Iambic Therapeutics raises USD 150m in Nasdaq IPO
StreetInsider
StreetInsider
·
19 წუთის წინ
Global S&P Futures mixed in premarket
Yahoo Finance
Yahoo Finance
·
2 საათის წინ
Buy 5 Top-Ranked Non-Tech Nasdaq Stocks to Maximize Q4 Gains
Profile
Zydus Wellness is an Indian consumer goods company, which produces nutrition and skincare products. Headquartered in Ahmedabad, it is a subsidiary of the pharmaceutical company Zydus Lifesciences. Its brands include Glucon-D, Sugar Free, EverYuth, Complan, and Nycil. As of 2021, the company operates three manufacturing plants, one in Gujarat and two in Sikkim. Wikipedia
About Zydus Wellness Ltd
CEOტარუნ ჯი არორა
Employees1,68 ათ.
Founded1994
Headquarters-
Sector-
Last report
4 აგვ. 2026
Fiscal period
Q1 2027
3,74 INR / 3,93 INR
-4,92%miss
Revenue / Est. (INR)
14,37 მლრდ. / 14,66 მლრდ.
-1,96%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
6,50 მლრდ.
9,65 მლრდ.
14,85 მლრდ.
14,37 მლრდ.
Cost of goods sold
3,06 მლრდ.
3,53 მლრდ.
5,43 მლრდ.
4,93 მლრდ.
Cost of revenue
3,06 მლრდ.
3,53 მლრდ.
5,43 მლრდ.
4,93 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,60 მლრდ.
2,53 მლრდ.
4,47 მლრდ.
3,58 მლრდ.
Operating expense
3,48 მლრდ.
6,07 მლრდ.
7,32 მლრდ.
7,59 მლრდ.
Total operating expenses
6,54 მლრდ.
9,60 მლრდ.
12,75 მლრდ.
12,52 მლრდ.
Operating income
-37,00 მლნ.
48,00 მლნ.
2,10 მლრდ.
1,85 მლრდ.
Other non operating income
14,00 მლნ.
8,00 მლნ.
-71,00 მლნ.
38,00 მლნ.
EBT including unusual items
-506,00 მლნ.
-415,00 მლნ.
1,77 მლრდ.
1,62 მლრდ.
EBT excluding unusual items
-164,00 მლნ.
-349,00 მლნ.
1,74 მლრდ.
1,62 მლრდ.
Income tax expense
22,00 მლნ.
-16,00 მლნ.
153,00 მლნ.
432,00 მლნ.
Effective tax rate
-4,35%
3,86%
8,63%
26,65%
Other operating expenses
1,63 მლრდ.
2,99 მლრდ.
2,29 მლრდ.
3,44 მლრდ.
Net income
-528,00 მლნ.
-399,00 მლნ.
1,62 მლრდ.
1,19 მლრდ.
Net profit margin
-8,12%
-4,14%
10,91%
8,27%
Earnings per share
-0,58
-1,06
5,09
3,74
Interest and investment income
-
-
14,00 მლნ.
-
Interest expense
-157,00 მლნ.
-412,00 მლნ.
-356,00 მლნ.
-263,00 მლნ.
Net interest expenses
-157,00 მლნ.
-412,00 მლნ.
-342,00 მლნ.
-263,00 მლნ.
Depreciation and amortization charges
251,00 მლნ.
555,00 მლნ.
553,00 მლნ.
571,00 მლნ.
EBITDA
142,50 მლნ.
112,50 მლნ.
2,46 მლრდ.
2,20 მლრდ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები